Arcus Biosciences (RCUS) Free Cash Flow (QoQ) (2017 - 2026)
Arcus Biosciences (RCUS) Free Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arcus Biosciences | 3.59 Bn | 2.77 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.05% |
| Dec 31, 2025 | -24.74% |
| Sep 30, 2025 | 27.07% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -41.49% |
| Dec 31, 2024 | -304.35% |
| Sep 30, 2024 | 147.42% |
| Jun 30, 2024 | -3,133.33% |
| Mar 31, 2024 | 97.00% |
| Dec 31, 2023 | -49.25% |
| Sep 30, 2023 | -17.54% |
| Jun 30, 2023 | 46.23% |
| Mar 31, 2023 | -47.22% |
| Dec 31, 2022 | 14.29% |
| Sep 30, 2022 | -33.33% |
| Jun 30, 2022 | -109.68% |
| Mar 31, 2022 | 1,179.12% |
| Dec 31, 2021 | -2.54% |
| Sep 30, 2021 | 16.83% |
| Jun 30, 2021 | -2.37% |